產(chǎn)品分類
Product Category
CHIR-99021 (CT99021) HCl 1797989-42-4 CHIR-99021 monohydrochloride is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM; 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2,
Zoldonrasib(RMC-9805)是一類有效、first-in-class 的小分子共價(jià)抑制劑,特異性靶向激活態(tài)(GTP-bound,ON)KRAS G12D突變蛋白,屬于創(chuàng)新型三元復(fù)合體(tri-complex)RAS (ON) 抑制劑。產(chǎn)品由 Revolution Medicines 開發(fā),目前處于臨床 I/II 期,用于 KRAS G12D 突變實(shí)體瘤(胰腺癌、結(jié)直腸癌、非小細(xì)胞
Daraxonrasib(RMC-6236)是有效的新型三元復(fù)合物型泛活化態(tài) RAS(RAS (ON))多選擇性抑制劑,可強(qiáng)效非共價(jià)結(jié)合 GTP 結(jié)合態(tài)的多種 RAS 突變體(包括 KRAS、NRAS、HRAS 的野生型及 G12X/G13X/Q61X 等突變體),阻斷 RAS 與下游效應(yīng)蛋白的相互作用,抑制 ERK 磷酸化,從而發(fā)揮抗腫瘤活性。本品為科研級試劑,適用于 RAS
DNQX 2379-57-9 is a non-N-methyl-D-aspartate (non-NMDA) receptor complex antagonist.
Cyclosporin A 59865-13-3 CyclosporinA是一種免疫抑制劑,與親環(huán)素結(jié)合,隨后抑制calcineurin,無細(xì)胞試驗(yàn)中IC50為7nM,廣泛用于預(yù)防器guan移植反應(yīng)中的排斥反應(yīng)。
CNQX disodium salt 479347-85-8 CNQX disodium salt is a potent and competitive GluR (kainate/quisqualate (non-NMDA) receptor) antagonist.
CNQX 115066-14-3 CNQX (FG9065) 是高效的 AMPA/kainate 受體拮抗劑。
CHIR-99021 trihydrochloride 1782235-14-6 CHIR-99021 trihydrochloride is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM;

電話
微信掃一掃